News
Latest news in the field of endometriosis: clinical and scientific research, updates from national support groups – and general news on progress.
Public-private partnership tackles major challenges in the care of pain patients
EU-funded consortium provides hope for women with endometriosis with chronic pain – €23 million funding secured.
Diagnostic biomarkers for endometriosis
Development of low-invasive tests/biomarkers for endometriosis remains a high priority in improving the diagnosis, management, and prognosis (progression/regression) of endometriosis. To date there are no reliable / validated tests.
Endometriosis and hysterectomy
Hysterectomy does not guarantee a relief from endometriosis-related symptoms and can neither be classified as a “treatment”, nor as a “cure” for endometriosis; it may relieve co-existing adenomyosis.
Endometriosis awareness 2018
Schedule of events for endometriosis awareness in 2018. Please join and contribute to these events so that together we can spread information about endometriosis and its impact on women. Get involved and help make a difference!
Endometriosis and cancer
Cause and effect between endometriosis and cancer has not been established yet, and future studies must prove causality rather than mere association – here is what we presently know about cancer risk factors.
ASRM2017: progress in endometriosis, but a vital step is missing
At ASRM2017 it was apparent that true research progress will not happen until sub-groups (phenotypes) of endometriosis are identified.
ESHRE2017: Endometriosis highlights
Endometriosis sessions at ESHRE’s 33rd Annual Scientific Meeting were better attended than ever – and were all about finding the balance between medical and surgical therapies for the individual woman.
ESHRE2017: Measuring and enhancing endometrial receptivity to improve pregnancy outcomes
Packed endometriosis special interest group pre-congress course at ESHRE in Geneva.
World Congress on Endometriosis empowers women through advocacy and education
When like-minded individuals come together with a selfless, common, goal to champion the cause, we can truly lead positive change in the field of endometriosis.
WCE2017: Phase III data for elagolix shows potential as treatment for endometriosis
Efficacy and safety of two different doses of elagolix, a GnRH antagonist, presented at World Congress on Endometrosis.
